Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study

[1]  S. Horvath,et al.  Leukocyte telomere length, T cell composition and DNA methylation age , 2017, Aging.

[2]  G. Tinsley,et al.  Physical activity and telomere length: Impact of aging and potential mechanisms of action , 2017, Oncotarget.

[3]  D. Absher,et al.  CPT1A methylation is associated with plasma adiponectin. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  T. Lehtimäki,et al.  Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals , 2017, Clinical Epigenetics.

[5]  M. Levine,et al.  Epigenetic clock analysis of diet, exercise, education, and lifestyle factors , 2017, Aging.

[6]  M. Feldman,et al.  Trends in DNA Methylation with Age Replicate Across Diverse Human Populations , 2016, Genetics.

[7]  M. Levine,et al.  DNA methylation-based measures of biological age: meta-analysis predicting time to death , 2016, Aging.

[8]  M. Levine,et al.  An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease , 2016, Genome Biology.

[9]  J. Tyler,et al.  Epigenetics and aging , 2016, Science Advances.

[10]  H. Brenner,et al.  Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort , 2016, Clinical Epigenetics.

[11]  D. Absher,et al.  Estimation of Cell-Type Composition Including T and B Cell Subtypes for Whole Blood Methylation Microarray Data , 2016, Front. Genet..

[12]  Naomi R. Wray,et al.  Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling , 2015, Genome Biology.

[13]  I. Borecki,et al.  Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). , 2015, Metabolism: clinical and experimental.

[14]  S. Horvath,et al.  DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.

[15]  Steve Horvath,et al.  The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936 , 2015, International journal of epidemiology.

[16]  L. Liang,et al.  Epigenome-Wide Association Study of Fasting Blood Lipids in the Genetics of Lipid-Lowering Drugs and Diet Network Study , 2014, Circulation.

[17]  G. Norata,et al.  Postprandial lipemia as a cardiometabolic risk factor , 2014, Current medical research and opinion.

[18]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[19]  Max Costa,et al.  Nutritionally Mediated Oxidative Stress and Inflammation , 2013, Oxidative medicine and cellular longevity.

[20]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[21]  J. Ordovás,et al.  The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat , 2012, PloS one.

[22]  Donna K Arnett,et al.  A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network , 2012, Pharmacogenetics and genomics.

[23]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[24]  Vanda M. Lourenço,et al.  Robust linear regression methods in association studies , 2011, Bioinform..

[25]  Helen Christensen,et al.  Is telomere length a biomarker of aging? A review. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  I. Borecki,et al.  Smoking, inflammatory patterns and postprandial hypertriglyceridemia. , 2009, Atherosclerosis.

[27]  D. Allison,et al.  Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study , 2009, Pharmacogenetics and genomics.

[28]  D. Arnett,et al.  Effect of influenza vaccine on markers of inflammation and lipid profile. , 2005, The Journal of laboratory and clinical medicine.

[29]  J. Rutledge,et al.  Postprandial lipemia and cardiovascular disease , 2003, Current atherosclerosis reports.

[30]  J. K. Dunn,et al.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  M. Bonyhadi,et al.  Cell isolation and expansion using Dynabeads. , 2007, Advances in biochemical engineering/biotechnology.